Exosome Characterization & Analytical Development – What Is It About?
Across three days in April, this hotly anticipated summit brought together key experts from AbbVie, Aegle Therapeutics, Vesigen Therapeutics, and more to unite an industry on:
- In depth technical content of exosome analysis and parameters for confidence in quality
- Defining standardized tools and techniques while keeping regulatory guidance in mind for clinical progression
- Bridging communications and networking between Analytical Experts and Decision Makers
You Could Have Joined Your Peers To:
Discover novel data from pioneering companies to benchmark best practices and ensure exosomes are reaching their full potential
Build your understanding of how key challenges should be tackled collaboratively, alongside how others are overcoming them with the use of new analytical tools
Engage with your peers from large pharma and biotech companies to drive collaborative initiatives and cultivate impactful partnerships for longevity.
Who Would You Have Met?
You could have joined industry thought-leaders from Large Pharma, Biotech’s and Academia to collaborate on ideas and findings surrounding future clinical developments.
What Your Peers Have To Say
“The line-up of speakers and lots of new data presented made this conference especially worthwhile”
Astellas
“A space for most recent technology to be showcased to identify which companies are making machines, devices and equipment for characterising exosomes”
Vivasome
